Izak gesels met prof. Colleen Aldous, ‘n gesondheidsorgwetenskaplike aan die Universiteit van Kwazulu Natal. Benewens die onderhoud, het sy ook ‘n baie interessante artikel geskryf waarin sy Dr Marthinus Viljoen se argumente teen die gebruik van Ivermektien bespreek. Die artikel kan op ons webtuiste gelees word Full video:
Video: Covid-19 treatment – The chain of survival from primary care to ICU
Presented on 30 June 2021
Video: The 1st Ivermectin for Covid-19 Summit
Please find full coverage of the 1st International Ivermectin for Covid 19 Summit below. Please share as widely as possible. Media are free to repackage and use segments below. Full coverage
Video: Ivermectin as a Prophylaxis
Dr Martin Gill advocates for the use of Ivermectin to stop the spread of Covid-19.
Zimbabwe government approves Ivermectin
NewDay reported on Friday that the Zimbabwe government has authorised imports of the Covid-19 drug Ivermectin. GOVERNMENT has approved mass importation of the veterinary anti-parasitic drug, Ivermectin, as it battles the second wave of COVID-19 infections which have rattled President Emmerson Mnangagwa’s administration after killing five government ministers. Robert Mudyiradima, the acting Health secretary wrote…
SAHPRA must remove red tape – Dr Martin Gill on Newzroom Afrika
Dr Martin Gill appears on Newszroom Afrika to explain the role of Ivermectin as a prophylactic and a treatment for Covid-19. “When you’re seeing a lot of patients, you don’t need this extra burden on you, ” Dr Gill said of the regulations surrounding Section 21 use of the drug in South Africa.
The case for Ivermectin – Dr Martin Gill on Radio Islam International
Radio Islam International · The case for Ivermectin – Dr. Martin Gill
Dr Andrew Hill presents latest meta-analysis data on Ivermectin to South African doctors (19 January 2020)
Watch the full webinar below courtesy of the Minara Chamber of Commerce.
Ivermectin and South Africa: Interview with Dr Marik, Dr Kory, Dr Gill and Dr Kathrada on 17 January 2021
Watch the full broadcast here.